These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9016847)

  • 1. Immunocytochemical detection of anti-hippocampal antibodies in Alzheimer's disease and normal cerebrospinal fluid.
    Loeffler DA; Juneau PL; Nguyen HU; Najman D; Pomara N; LeWitt PA
    Neurochem Res; 1997 Feb; 22(2):209-14. PubMed ID: 9016847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease cerebrospinal fluid antibodies display selectivity for microglia. Investigations with cell cultures and human cortical biopsies.
    Dahlström A; McRae A; Polinsky R; Nee L; Sadasivan B; Ling EA
    Mol Neurobiol; 1994; 9(1-3):41-54. PubMed ID: 7888106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease.
    Kankaanpää J; Turunen SP; Moilanen V; Hörkkö S; Remes AM
    Neurobiol Dis; 2009 Mar; 33(3):467-72. PubMed ID: 19130885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: preliminary studies.
    McIntyre JA; Chapman J; Shavit E; Hamilton RL; Dekosky ST
    Autoimmunity; 2007 Jul; 40(5):390-6. PubMed ID: 17612901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal and nonneuronal quantitative BACE immunocytochemical expression in the entorhinohippocampal and frontal regions in Alzheimer's disease.
    Leuba G; Wernli G; Vernay A; Kraftsik R; Mohajeri MH; Saini KD
    Dement Geriatr Cogn Disord; 2005; 19(4):171-83. PubMed ID: 15677864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid microglial antibodies: potential diagnostic markers for immune mechanisms in Alzheimer's disease.
    McRae A; Dahlström A; Polinsky R; Ling EA
    Behav Brain Res; 1993 Nov; 57(2):225-34. PubMed ID: 8117427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown.
    Levin EC; Acharya NK; Han M; Zavareh SB; Sedeyn JC; Venkataraman V; Nagele RG
    Brain Res; 2010 Jul; 1345():221-32. PubMed ID: 20546711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease.
    Costa A; Bini P; Hamze-Sinno M; Moglia A; Franciotta D; Sinforiani E; Ravaglia S; Bole-Feysot C; Hökfelt T; Déchelotte P; Fetissov SO
    J Neuroimmunol; 2011 Dec; 240-241():114-20. PubMed ID: 22078238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial cerebrospinal fluid antibodies. Significance for Alzheimer disease.
    McRae A; Ling EA; Wigander A; Dahlström A
    Mol Chem Neuropathol; 1996; 28(1-3):89-95. PubMed ID: 8871946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease.
    Ikonomovic MD; Mizukami K; Warde D; Sheffield R; Hamilton R; Wenthold RJ; Armstrong DM
    Exp Neurol; 1999 Nov; 160(1):194-204. PubMed ID: 10630204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal RNA in relation to Alz-50 immunoreactivity in Alzheimer's disease.
    Doebler JA; Markesbery WR; Anthony A; Davies P; Scheff SW; Rhoads RE
    Ann Neurol; 1988 Jan; 23(1):20-4. PubMed ID: 2449843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity of calcium binding protein secretagogin in the human hippocampus is restricted to pyramidal neurons.
    Attems J; Quass M; Gartner W; Nabokikh A; Wagner L; Steurer S; Arbes S; Lintner F; Jellinger K
    Exp Gerontol; 2007 Mar; 42(3):215-22. PubMed ID: 17116382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-D-aspartate glutamate receptor antibodies in dementias.
    Busse M; Kunschmann R; Dobrowolny H; Hoffmann J; Bogerts B; Steiner J; Frodl T; Busse S
    Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):483-492. PubMed ID: 28176002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease.
    Kountouras J; Boziki M; Gavalas E; Zavos C; Deretzi G; Grigoriadis N; Tsolaki M; Chatzopoulos D; Katsinelos P; Tzilves D; Zabouri A; Michailidou I
    Int J Neurosci; 2009; 119(6):765-77. PubMed ID: 19326283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies in the cerebrospinal fluid of some Alzheimer's disease patients recognize amoeboid microglial cells in the developing rat central nervous system.
    McRae A; Ling EA; Polinsky R; Gottfries CG; Dahlström A
    Neuroscience; 1991; 41(2-3):739-52. PubMed ID: 1870709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal expression and induction of glutamate decarboxylase and GABA in excitatory granule cells of the rat and monkey hippocampal dentate gyrus.
    Sloviter RS; Dichter MA; Rachinsky TL; Dean E; Goodman JH; Sollas AL; Martin DL
    J Comp Neurol; 1996 Sep; 373(4):593-618. PubMed ID: 8889946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
    Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
    Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between naturally occurring anti-amyloid β autoantibodies and medial temporal lobe atrophy in Alzheimer's disease.
    Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Inuzuka T
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):126-131. PubMed ID: 27330118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune complexes of auto-antibodies against A beta 1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients.
    Henkel AW; Dittrich PS; Groemer TW; Lemke EA; Klingauf J; Klafki HW; Lewczuk P; Esselmann H; Schwille P; Kornhuber J; Wiltfang J
    Mol Psychiatry; 2007 Jun; 12(6):601-10. PubMed ID: 17279093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer's diseased brain.
    Brady DR; Mufson EJ
    Neuroscience; 1997 Oct; 80(4):1113-25. PubMed ID: 9284064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.